Depression News

HHS announced it awarded $40.22 million in youth mental health grants during August, as well as the opportunity for $47.6 million in grant funding for school-based mental health services.

It was Monday morning, I had researched and prepped the day’s patients. Most new, some complicated.

Adults with type 2 diabetes or a sleep disorder have an increased risk for depression compared with those with neither condition, according to data published in the Journal of Diabetes and Its Complications.

Strong associations between the genetic risk for suicide attempts in adults and their offspring were reported in a case-control study published in JAMA Psychiatry.

Sleeve gastrectomy for class 1 obesity led to more weight loss and diabetes prevention compared with intensive lifestyle modification but was linked to higher risks for substance use disorder and self-harm, according to new data.

BrainsWay Ltd. announced it has received 510(k) clearance from the FDA for its Deep TMS H7 Coil for use in treating adults with major depressive disorder, as well as comorbid anxiety.

Introducing electroconvulsive therapy earlier in a treatment course for major depressive disorder or bipolar disorder may lead to improvements in clinical outcomes, according to a study published in the Journal of Clinical Psychiatry.

Freedom Biosciences, a startup biotechnology firm, announced it has secured $10.5 million in seed financing to advance its lead ketamine program as well as additional exploratory programs in psychedelic-based mental health.

Implementing routine depression screening in primary care substantially increased screening rates, particularly among those at risk for undertreatment, according to a study published in JAMA Network Open.

Gate Neurosciences is developing a new portfolio of next-generation therapeutics to treat synaptic dysfunction in patients with central nervous system disorders, the company announced in a press release.